Robert Stratta to Cyclosporine
This is a "connection" page, showing publications Robert Stratta has written about Cyclosporine.
Connection Strength
0.491
-
Pozniak MA, Kelcz F, D'Alessandro A, Oberley T, Stratta R. Sonography of renal transplants in dogs: the effect of acute tubular necrosis, cyclosporine nephrotoxicity, and acute rejection on resistive index and renal length. AJR Am J Roentgenol. 1992 Apr; 158(4):791-7.
Score: 0.102
-
Stratta RJ. Experience with azathioprine withdrawal after simultaneous kidney-pancreas transplantation. Transplant Proc. 1998 Jun; 30(4):1353-4.
Score: 0.039
-
Stratta RJ. Late acute rejection episodes after vascularized pancreas transplantation. Transplant Proc. 1998 Jun; 30(4):1560-1.
Score: 0.039
-
Elmer DS, Abdulkarim AB, Fraga D, Shokouh-Amiri H, Stratta RJ, Hathaway DK, Reddy K, Gaber AO. Metabolic effects of FK 506 (tacrolimus) versus cyclosporine in portally drained pancreas allografts. Transplant Proc. 1998 Mar; 30(2):523-4.
Score: 0.038
-
Stratta RJ, Taylor RJ, Castaldo P, Sindhi R, Sudan D, Weide LG, Frisbie K, Cushing KA, Jerius J, Radio SJ. FK 506 induction and rescue therapy in pancreas transplant recipients. Transplant Proc. 1996 Apr; 28(2):991-2.
Score: 0.034
-
Henley SE, Larsen JL, Mack-Shipman L, Miller SA, Cushing KA, Stratta RJ. Lipids following pancreas transplantation in recipients receiving FK 506. Transplant Proc. 1995 Dec; 27(6):2997.
Score: 0.033
-
Brennan DC, Stratta RJ, Lowell JA, Miller SA, Taylor RJ. Cyclosporine challenge in the decision of combined kidney-pancreas versus solitary pancreas transplantation. Transplantation. 1994 Jun 15; 57(11):1606-11.
Score: 0.030
-
Stratta RJ, Taylor RJ, Lowell JA, Bynon JS, Cattral M, Langnas AN, Shaw BW. Selective use of Sandostatin in vascularized pancreas transplantation. Am J Surg. 1993 Dec; 166(6):598-604; discussion 604-5.
Score: 0.029
-
Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J, et al. Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group. Transplant Proc. 1993 Feb; 25(1 Pt 1):635-7.
Score: 0.027
-
Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J, et al. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. Transplant Proc. 1993 Feb; 25(1 Pt 1):641-3.
Score: 0.027
-
Wisecarver JL, Earl RA, Haven MC, Timmins PW, Shaw BW, Stratta RJ, Langnas AN, Zetterman RK, Donovan JP, Shaefer MS, et al. Histologic changes in liver allograft biopsies associated with elevated whole blood and tissue cyclosporine concentrations. Mod Pathol. 1992 Nov; 5(6):611-6.
Score: 0.027
-
Hardinger KL, Stratta RJ, Egidi MF, Alloway RR, Shokouh-Amiri MH, Gaber LW, Grewal HP, Honaker MR, Vera S, Gaber AO. Renal allograft outcomes in African American versus Caucasian transplant recipients in the tacrolimus era. Surgery. 2001 Oct; 130(4):738-45; discussion 745-7.
Score: 0.012
-
Shokouh-Amiri MH, Egidi MF, Lo A, Grewal HP, Vera SR, Stratta RJ, Kizilisik T, Nezakatgoo N, Trofe J, Alloway RR, Cowan PA, Gaber AO. The importance of early prevention of renal dysfunction in liver transplant recipients. Transplant Proc. 2001 Feb-Mar; 33(1-2):1399-400.
Score: 0.012
-
Chinnakotla S, Taylor RJ, DeRoover A, Stratta RJ, Leone JP. Fate of the pancreas after asynchronous kidney loss in patients undergoing simultaneous kidney/pancreas transplantation. Transplant Proc. 2001 Feb-Mar; 33(1-2):1696-7.
Score: 0.012
-
Henley SA, Akhter J, Stratta RJ, Mack-Shipman LR, Miller SJ, Frisbie K, Taylor R, Erickson JM, Leone JP, Lyden E, Ratanasuwan T, Larsen JL. Lipids increase after solitary pancreas transplantation. Diabetes Care. 1999 Feb; 22(2):320-7.
Score: 0.010
-
Trail KC, Stratta RJ, Larsen JL, Langnas AN, Donovan JP, Sorrell MF, Zetterman RK, Taylor RJ, Shaw BW. Orthotopic hepatic transplantation in patients with type I diabetes mellitus. J Am Coll Surg. 1994 Apr; 178(4):337-42.
Score: 0.007
-
Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J, et al. Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. Transplant Proc. 1993 Feb; 25(1 Pt 1):679-88.
Score: 0.007
-
Shaw BW, Markin R, Stratta R, Langnas A, Donovan J, Sorrell M. FK 506 for rescue treatment of acute and chronic rejection in liver allograft recipients. Transplant Proc. 1991 Dec; 23(6):2994-5.
Score: 0.006